Acute ischemic stroke: low-dose tPA is effective, safer

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Among patients undergoing intravenous thrombolysis for acute ischemic stroke, low-dose tissue plasminogen activator (tPA) yielded similar odds of good functional outcome and lower odds of symptomatic intracranial hemorrhage vs standard dose.

Why this matters           ...